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Abstract 
Interleukin-8 (IL-8), is a potent activator of polymorphonuclear leukocyte (PMN) functions including 
chemotaxis, superoxide anion production, and enzyme release and it is also chemotactic for lymphocytes. 
Additionally, it has recently been shown that IL-8 stimulates the formation of 5-1ipoxygenase (LO) 
products of arachidonic acid (AA) by human PMNs. The purpose of the present study was to determine 
whether IL-8 also might affect the formation of 15-LO products from AA. Purified PMNs in phosphate 
buffered saline were preincubated with and without exogenous AA (10-5_ 10-4 M) for 10 min. Then 
IL-8 was added in biologically relevant concentrations ranging from 0.1 to 100 ng/ml and incubation was 
carried out for 5 min at 37 ~ Lipids were then extracted from supernatants, and eicosanoids were 
determined by quantitative RP-HPLC. Compared with unstimulated cells, IL-8 resulted in a dose 
dependent increase in both LTB 4 and 15-HETE (up to 125% and 40% at 100 ng/ml, respectively). This 
increase in eicosanoid formation required the presence of exogenous AA. These results indicate that IL-8 
is both a potent stimulator of 5-LO activity and of 15-LO activity. LTB 4 can induce both inflammation 
and contribute to hyperproliferation in the skin. 15-HETE in contrast has the ability to inhibit the effects 
induced by LTB 4. Because IL-8 is able to stimulate both LTB 4 and 15-HETE formation, the effect of 
IL-8 as a putative regulator of inflammatory processes may be dependent on the relative stimulation of 
5-LO and 15-LO. 
Introduction 
A variety of proinflammatory mediators are re- 
leased in cutaneous inflammation. These media- 
tors include peptide-like substances, interleukin-I 
[1, 2], complement C5a [3, 4] and bacterial F-Met 
peptides [5] and lipid-like mediators derived from 
arachidonic acid, leukotriene B 4 (LTB4) and 12- 
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hydroxy-eicosatetraenoic acid (12-HETE) [6, 7] 
and platelet activating factor (PAF) [8]. LTB 4 and 
12-HETE are proinflammatory in human skin sug- 
gested by their ability to cause skin inflammation 
[9, 10] and epidermal proliferation [11] after topi- 
cal application. 
15-HETE is also a metabolite of AA formed by the 
15-LO, but in contrast to LTB4 it has no proin- 
flammatory effect in the skin. It inhibits both the 
formation [12] and the in vitro and in vivo effects of 
LTB 4 [13, 14]. Thus 15-HETE has antiinflammato- 
ry potential. In support of this is the observed 
improvement of  psoriasis after intralesional injec- 
tions of 15-HETE [15] and the improvement of 
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carragheenan-induced experimental arthritis in 
dogs [16]. The regulation of eicosanoid release 
from human cells is poorly understood. It has been 
shown that the complement product C5a, FMLP 
and PAF have the capacity to stimulate the release 
of LTB 4 from neutrophils in vitro [17, 18]. It is 
unknown which factors are involved in the release 
of 15-HETE. However, it has been shown that 
substrate by itself initiates the production of 15- 
HETE and other 15-LO products [19, 20]. Also, it 
has been shown that 15-LO activity can be in- 
creased by certain non-steroidal antiinflammatory 
drugs/5-LO inhibitors [21, 22] and by certain hy- 
droxy-eicosatetraenoic acids [23]. 
IL-8, formerly known as neutrophil-activating 
protein (NAP-I) [24, 25] is a newly discovered cy- 
tokine with the capacity to activate neutrophils 
[24, 26] and T lymphocytes in vitro as well as in vivo 
[24]. IL-8 can be produced by several different cell 
types present in the human skin including kerati- 
nocytes, fibroblasts [27] and endothelial cells [28]. 
Schr6der et al. [3] purified considerable quantities 
of IL-8 from extracts of psoriatic scales suggesting 
a pathophysiological role of this leukocyte activat- 
ing cytokine in the development of psoriasis. 
It has recently been shown that IL-8 can stimulate 
the formation of LTB 4 and its omega-oxidation 
products by human neutrophils [25, 29]. The pur- 
pose of the present study was to determine whether 
IL-8 might affect not only the formation of LTB 4 
but also the formation of 15-HETE. 
Materials and methods 
Cell preparation 
Blood was obtained from healthy human volun- 
teers, who had not taken non-steroidal antiinflam- 
matory drugs during the preceding 2 weeks. Neu- 
trophils were prepared as previously described 
[22]. After isolation the cells were suspended at a 
concentration of 12 x 106/ml in phosphate 
buffered saline (PBS, Sigma) without calcium and 
magnesium, pH 7.0. Cells were kept at 4~ until 
analysis. 
Incubation procedure 
820 ~tl neutrophils (12 x 106 cells/ml) were preincu- 
bated for 10 rain at 37~ with or without exoge- 
nous AA (99% pure, Sigma) at the concentrations 
mentioned. Then 100 Ixl of stock solutions (1 ng/ 
ml-1 mg/ml in PBS) of recombinant IL-8 (Dianip- 
pon Pharmac, Japan) were added together with 
40 ~tl CaC12 (final concentration of 3.6 mM) and 
40 rtl MgC1 z (final concentration of 1.9 raM). In 
incubations with ionophore A23187 (Sigma) 
A23187 was added as 100 gl of a stock solution 
(50 gM, 1% ethanol). Incubations were carried 
out for 5 rain. at 37~ in a shaking water bath. 
Control incubations without AA and without IL-8 
or A23187 were carried out in the presence of 
ethanol. AA and A23187 were dissolved in ethanol 
and the final alcohol concentration never exceeded 
0.2%. The incubations were terminated by cooling 
to 0 ~ in an ice water bath. 
Extraction of lipids 
After centrifugation (1,500 g for 10 min at 0~ 
the supernatant was collected and 2 ml of icecold 
methanol was added. This mixture was kept at 
- 2 0 ~  for 15min and centrifuged (1,500 g for 
10 min at 0 ~ to pellet cellular debris and dena- 
tured protein and the supematant was collected. 
Lipids were then extracted as previously described 
[22]. Briefly, the acidified supernatant (pH 3) was 
applied to ODS (octadecylsilyl) silica columns 
(C18-SEP-PAK, Waters, USA), and eluted sequen- 
tially with 2 ml water, 2 ml 25% methanol, 2 ml 
petroleum ether and 3 ml methanol. The methanol 
fraction was taken to dryness under a stream of N 2 
and resuspended in 70% methanol. 
Reversed-phase high performance liquid 
chromatography ( RP-HPLC) 
Extracted lipids were separated by RP-HPLC as 
previously described. RP-HPLC was performed 
using a,system from Waters consisting of two M- 
6000A pumps, a Hypersil C18-column (5 gin, 
100 x 4.6 mm I.D.), a model 490 programmable 
UV-detector, a model 730 data module and a mod- 
el 721 system controller. The elution program was 
a modified isocratic method using methanol/wa- 
ter/acetic acid, 70:30:0.01 (v/v/v) as the mobile 
phase (solvent A). For the first 10 min the flow rate 
was 0.75 ml/min and thereafter the flow rate was 
increased to 1.25 ml/min. At 35 rain the mobile 
phase was changed to 100% methanol (solvent B) 
for 10 min to elute unreacted AA. Thereafter the 
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Effect of IL-8 on 15-HETE formation by human neutrophils. 
820 pl neutrophils (12x 106 cells/ml) were preincubated for 
10 rain at 37 ~ in the presence of AA. Then 100 gl of stock 
solutions (1 ng/ml- ling/l) of IL-8 were added together with 40 gl 
CaC12 (final concentration of 3.6 mM) and 40 gl MgC12 (final 
concentration of 1.9 raM). Incubations were carried out for 
5 rain at 37 ~ in a shaking water bath. 15-HETE was determined 
by integrated optical density. Results are expressed as mean 
+ SEM of 6 experiments assayed in duplicate. *: IL-8 vs. control. 
I N T E R L E U K I N  - 8 
EFFECT OF AA ON 15- HETE 
100 
N ~o 
G 8o 
/ 70. 
1 6o. 
0 50. 
40.  
M 30. ~ *  
I 2o. 
L Io. 0 
L 0 25 50 100 
_ IL-88~ 
+ Ik- 
~: 50 NG/M~ 
Fig.re z AA 0JM) 
Effect of exogenous AA on IL-8 stimulated 15-HETE formation 
by human neutrophils. 820 gI neutroplails (12x l0 ~ cells/ml) 
were preincubated for 10min at 37~ in the presence of AA 
(0-100 p.M). Then 100/al of a stock solution (0.5 mg/l) of IL-8 
were added together with 40 gl CaCI 2 (final concentration of 
3.6 raM) and 40 gl MgCI 2 (final concentration of 1.9 raM). Incu- 
bations were carried out for 5 rain at 37 ~ in a shaking water 
bath. 15-HETE was determined by integrated optical density. 
Results are expressed as mean_+ SEM of 6 experiments assayed in 
duplicate. *: IL-8 vs. control. 
co lumn was re-equilibrated with solvent A before 
the next analysis. The UV-detector was pro- 
grammed to 270 nm from 0 - 1 5  min and to 235 nm 
from 15-35  min. The eluent was monitored by the 
UV-detector producing the UV-absorpt ion as a 
function of wavelength for each chromatographic 
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peak. Quantif icat ion of fatty acid metabolites was 
made by comparison of integrated areas of un-  
known peaks with those of authentic standards. 
All peaks in the chromatograms were identified 
and no unknow n  peaks were seen [22]. Recovery of 
3H-labeled eicosanoids as internal standards was 
determined by scintillation counting in a Tricarb 
scintillation counter  as previously described [22]. 
Tritiated standards were added before extraction 
and purification. The elution times were standard- 
ized daily. The eluent was collected by a fraction 
collector programmed to collect 1 rain fractions. 
Statistical Analysis 
Results are expressed as the mean_+ standard error 
of the mean (SEM). Statistical significance was 
assessed by Wilcoxon's  ranksum test. A p value 
below 0.05 was considered significant. 
Results 
Fig. 1 shows the effect of  IL-8 on the formation of 
15-HETE,  by human  neutrophils in vitro in the 
presence of 10 I~M AA. IL-8 lead to a dose-depen- 
dent increase in 15-HETE formation in the con- 
centrat ion range 0 .1 -100ng /ml .  At  100ng/ml 
there was a 40% increase in 15-HETE formation. 
For  comparison also LTB 4 formation was deter- 
mined and there was a 125% increase in LTB 4 at 
100 ng/ml (data not  shown). Incubat ions with 
10 pM AA, but  without IL-8 resulted in the forma- 
t ion of 4 . 7 + 0 . 9 n g  LTB4/107 cells and of 
6 .7+0.8  ng 15-HETE/107 cells. 
The increase in 15-HETE formation was depen- 
dent  on the presence of exogenous AA (Fig. 2) 
Increased concentrations of AA lead to an increase 
in 15-HETE formation. IL-8 had an additive effect 
on AA-induced eicosanoid formation. Also the 
formation of LTB4 formation was dependent  on 
the presence of exogenous AA (data not  shown). 
To assess the potency of IL-8 on eicosanoid forma- 
tion, the effect of the calcium ionophore A23187, 
a potent  activator of LTB 4 formation [30] was de- 
termined. 15-HETE release was increased 40% by 
IL-8 (100 ng/ml), whereas A23187 did not  cause 
any significant increase in the formation of 15- 
HETE (Fig. 3). In  contrast, A23187 (5 gM) in- 
duced a 550% increase in LTB 4 formation, 
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Comparison of IL-8 and A23187 on 15-HETE formation by 
human neutrophils. 820 gl neutrophils (12 x 106 cells/ml) were 
preincubated for 10min at 37~ in the presence of AA 
(0-100 gM). Then i00 ~tl of  a stock solution of IL-8 (1.0 mg/1, 
final concentration of 100 ng/ml) or A23187 (50 gM, final con- 
centration of 5 p.M) were added together with 40 p.1 CaC12 (final 
concentration of 3.6 mM) and 40 gl MgC12 (final concentration 
of 1.9 mM). Incubations were carried out for 5 min at 37 ~ in a 
shaking water bath. 15-HETE was determined by integrated op- 
tical density. Results are expressed as mean + SEM of 6 experi- 
ments assayed in duplicate. *: IL-8 vs. control, +:  A23187 vs 
control. 
whereas the IL-8 induced LTB 4 release was in- 
creased by 125% at 100ng/ml (data not shown). 
Discussion 
We have shown that IL-8 in a dose-dependent way 
increases the formation of LTB4 and 15-HETE by 
human neutrophils in vitro. This stimulation of 
both LTB4 and 15-HETE formation is dependent 
on the presence of exogenous arachidonic acid and 
therefore reflects increased activity of  5-LO and 
15-LO. 
IL-8 was formerly known as neutrophil-activating 
protein (NAP-/),  but we have recently suggested 
that this newly discovered cytokine should be 
termed interleukin-8 [24]. IL-8 has the capacity to 
stimulate a number of  neutrophil functions [25, 
26]. Furthermore, IL-8 is chemotactic for T 
lymphocytes [24]. It has recently been shown that 
IL-8 has the capacity to increase the formation of 
LTB4 from exogenous AA [25, 29]. In the present 
study we have confirmed this finding, and shown 
that in addition IL-8 also has the capacity to in- 
crease the formation of 15-HETE. 
The requirement for exogenous AA for LTB4 for- 
mation depends on the stimulus. The calcium 
ionophore A23187 leads to the formation of large 
amounts of LTB 4 without the addition of AA by a 
mechanism that involves a rise in intracellular cal- 
cium and an activation of phospholipase [31]. As 
with IL-8, the formation of LTB 4 induced by 
FMLP or C5a requires the presence of exogenous 
AA [17]. These findings indicate that these agents 
stimulate LTB 4 formation without activating 
phospholipase A 2. Thus, substrate availability 
seems to be critical for the stimulation of  LTB 4 
formation by IL-8. 
Activation of 15-LO is poorly understood. There is 
evidence that the formation of 15-HETE only re- 
quires substrate for product formation [19, 20] and 
we have previously shown that increase in 15- 
HETE formation by neutrophils is associated with 
an inhibition of LTB 4 formation [22]. In this study 
we have found that AA leads to the formation of 
relatively large amounts of 15-HETE and that IL-8 
is a potent stimulus for 15-HETE formation in 
contrast to A23187 that leads to no significant 
increase in 15-HETE formation (Fig. 3). However, 
the activation of  15-LO still remains to be clarified. 
The present results indicate that the activity of 
IL-8 may partly be mediated through an activation 
of the 5- and 15-LO pathways of arachidonic acid 
(i.e. of LTB~ and 15-HETE formation). Because 
LTB 4 and 15-HETE have opposite effects on in- 
flammatory processes (pro-inflammatory and an- 
ti-inflammatory, respectively), activation of their 
formation may be of importance in the regulation 
of inflammatory processes. Therefore, it remains 
to be determined whether IL-8 in vivo leads to an 
activation of LTB 4 and 15-HETE formation. 
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